TW360543B - Encapsulated pharmaceutical composition - Google Patents

Encapsulated pharmaceutical composition

Info

Publication number
TW360543B
TW360543B TW083105987A TW83105987A TW360543B TW 360543 B TW360543 B TW 360543B TW 083105987 A TW083105987 A TW 083105987A TW 83105987 A TW83105987 A TW 83105987A TW 360543 B TW360543 B TW 360543B
Authority
TW
Taiwan
Prior art keywords
pharmaceutical composition
encapsulated pharmaceutical
salt
insoluble compound
practically insoluble
Prior art date
Application number
TW083105987A
Other languages
English (en)
Inventor
Takehisa Hata
Fumio Shimojo
Kazutake Kado
Kyoko Ishii
Seiji Sawai
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of TW360543B publication Critical patent/TW360543B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
TW083105987A 1993-06-30 1994-06-29 Encapsulated pharmaceutical composition TW360543B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16098393 1993-06-30

Publications (1)

Publication Number Publication Date
TW360543B true TW360543B (en) 1999-06-11

Family

ID=15726345

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083105987A TW360543B (en) 1993-06-30 1994-06-29 Encapsulated pharmaceutical composition

Country Status (15)

Country Link
US (1) US5683716A (zh)
EP (1) EP0706380B1 (zh)
JP (1) JPH09501150A (zh)
KR (1) KR960703335A (zh)
CN (1) CN1087933C (zh)
AT (1) ATE204163T1 (zh)
AU (1) AU682192B2 (zh)
CA (1) CA2165789A1 (zh)
DE (1) DE69427981T2 (zh)
DK (1) DK0706380T3 (zh)
ES (1) ES2161768T3 (zh)
GR (1) GR3036407T3 (zh)
PT (1) PT706380E (zh)
TW (1) TW360543B (zh)
WO (1) WO1995001166A1 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
WO2001060353A1 (fr) * 2000-02-21 2001-08-23 Fujisawa Pharmaceutical Co., Ltd. Preparation liquide a absorbabilite amelioree
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
WO2002094173A2 (en) * 2001-05-22 2002-11-28 Euro-Celtique Tamper resistant oral dosage form
US20030077378A1 (en) * 2001-10-22 2003-04-24 Lou Wen Chin Hydroxypropyl cellulose encapsulation material
NZ584729A (en) * 2007-10-05 2012-12-21 Alzheimer S Inst Of America Inc Method for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis with (-)-nilvadipine enantiomer
JP5750278B2 (ja) * 2011-02-28 2015-07-15 東洋カプセル株式会社 カンデサルタンシレキセチルのカプセル充填用組成物
WO2014010008A1 (ja) * 2012-07-09 2014-01-16 東洋カプセル株式会社 カンデサルタンシレキセチルのカプセル充填用組成物
US11491088B2 (en) 2012-11-06 2022-11-08 CoLabs International Corporation Compositions containing a capsule with a moisturizing agent
US11724134B2 (en) 2012-11-06 2023-08-15 CoLabs International Corporation Compositions containing a cellulose derived capsule with a sunscreen active agent
US10322301B2 (en) 2012-11-06 2019-06-18 CoLabs International Corporation Compositions containing a cellulose derived capsule with a sunscreen active agent
US11690793B2 (en) 2012-11-06 2023-07-04 Colabs Int'l Corp. Composition containing a cellulose derived capsule with a sunscreen
US11707421B2 (en) 2012-11-06 2023-07-25 Colabs Int'l Corp. Compositions containing a flexible derived capsule with an active agent
JP2015536985A (ja) 2012-11-06 2015-12-24 コラブス インターナショナル コーポレーション 日焼け止めを含むセルロース由来カプセル含有組成物
EP3813786A4 (en) 2018-06-27 2022-06-29 Colabs International Corporation Compositions comprising silicon dioxide-based particles including one or more agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
GB8629761D0 (en) * 1986-12-12 1987-01-21 Harris Pharma Ltd Capsules
KR920008948B1 (ko) * 1987-02-12 1992-10-12 니혼 덴네쯔 게이기 가부시끼가이샤 프린트 기판의 납땜방법 및 그의 장치
US5340591A (en) * 1992-01-24 1994-08-23 Fujisawa Pharmaceutical Co., Ltd. Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine

Also Published As

Publication number Publication date
PT706380E (pt) 2002-02-28
CN1127990A (zh) 1996-07-31
ES2161768T3 (es) 2001-12-16
US5683716A (en) 1997-11-04
JPH09501150A (ja) 1997-02-04
EP0706380A1 (en) 1996-04-17
GR3036407T3 (en) 2001-11-30
KR960703335A (ko) 1996-08-17
DE69427981D1 (de) 2001-09-20
EP0706380B1 (en) 2001-08-16
AU682192B2 (en) 1997-09-25
CN1087933C (zh) 2002-07-24
DE69427981T2 (de) 2001-11-29
DK0706380T3 (da) 2001-10-08
ATE204163T1 (de) 2001-09-15
WO1995001166A1 (en) 1995-01-12
AU6984294A (en) 1995-01-24
CA2165789A1 (en) 1995-01-12

Similar Documents

Publication Publication Date Title
TW360543B (en) Encapsulated pharmaceutical composition
CA2214399A1 (en) Soft gelatin capsule with a gelatin shell comprising xanthine derivative
TW272195B (zh)
EP0695171A1 (en) LONOSPHERES CONTAINING GONADOTROPHIN
CA2168732A1 (en) Gelatin Capsules Containing a Highly Concentrated Acetaminophen Solution
OA09458A (en) Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof.
GR3005035T3 (zh)
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
DE59609926D1 (de) Stabilisierte schilddrüsenhormonhaltige arzneimittel
CA2156455A1 (en) Glycinamide Derivatives, Processes for Their Preparation and Medicines Containing Them
HUP9601321A3 (en) Substituted (benzyloxy)-carbonyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them their use as pharmaceutical compositions or diagnostica, and the use of the said compds.
HUP9602640A3 (en) Substituted benzoyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them and the use of the compds.
CA2094122A1 (fr) Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique
ES2004097A6 (es) Procedimiento de preparacion de un nuevo derivado triciclico denominado acido 5-(3-cloro-6-metil-5,5-dioxo-6,11-dihidro-(c,f)-dibenzo-(1,2)-tiazepin-11-il)amino)-pentanoico
EP0613690A3 (en) Compositions based on iodoanaline derivatives for visualizing the gastrointestinal tract.
ZA949347B (en) 1,4,7,10-tetraazacyclododecane derivatives, their use, pharmaceutical agents containing these compounds and process for their production.
WO2000016745A3 (en) Micronised pharmaceutical compositions
WO2001021140A3 (de) Kosmetische und/oder pharmazeutische zubereitungen
PL312987A1 (en) Gelatine capsule
HUT52072A (en) Microbicide compositions containing new halogeno-vinyl-azol derivatives as active components, and process for producing the active components
AU6991291A (en) 3-l-(5-thioxo-l-prolyl) thiazolidine-4-carboxylic acid and derivatives therefrom, processes for the preparation thereof and pharmaceutical compositions containing them
HUP9700104A3 (en) 1,3,4-thiadiazole derivatives, pharmaceutical compositions containing them as active component and process for producing the active component
UA23119A (uk) Психотропhий засіб
IT1226255B (it) Sigillo di garanzia per capsule metalliche e recipienti cosi' equipaggiati.
AR244683A1 (es) Agente para la produccion de plantas contra enfermedades.